• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Medicaid ends funding for child sex-change procedures as Trump admin slams ‘experimental’ treatments

by August 11, 2026
written by August 11, 2026

FIRST ON FOX: American taxpayers will no longer be on the hook for child sex-change hormones or surgeries, as a key Trump administration agency announced Tuesday that Medicaid will stop funding such procedures and therapies.

Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz tells Fox News Digital that the decision to implement a rule pulling the funding is “consistent with [the Trump administration’s] commitment to protect children from experimental and life-altering sex-rejecting procedures that carry serious long-term health risks and lack sufficiently reliable evidence of clinical benefit.”

CMS, an agency within the Department of Health and Human Services (HHS), says taxpayer-funded Children’s Health Insurance Program (CHIP) will also cease coverage of sex-change hormones and surgeries.

SEN HAWLEY WARNS IT WOULD BE ‘UNCONSCIONABLE’ IF BILLIONS OF TAXPAYER FUNDS FLOW TO TRANS KIDS’ SEX CHANGES

The rule will not affect mental health treatments for gender dysmorphia and other conditions, which will continue to be covered under Medicaid and CHIP.

The move comes after years of what conservatives called ‘woke’ policies that opened avenues for federal funding of therapies and procedures to allow children to physically — and oftentimes permanently — transition from their biological sex before they could legally drive, get a tattoo or enlist in the U.S. Military.

“Children deserve our protection, not experimental interventions that pose serious risks and convey no proven benefits,” Oz said. “By cutting off federal funds for these sex-rejecting procedures, we’re following the science, saving taxpayer dollars, and, most importantly, protecting children from potentially irreversible harm so they can truly flourish.”

Specifically, the “sex-rejecting” treatments that will no longer be covered include cross-sex hormones, puberty blockers and sex-change surgical operations.

CMS and HHS say such procedures “can result in irreversible damage, including infertility, impaired sexual function, diminished bone density, altered brain development, and other lasting physiological effects.”

HHS, under Secretary Robert F. Kennedy Jr., reviewed national and international research on sex-change procedures in minors, which ultimately informed CMS’ decision to reverse federal taxpayer-funded procedures.

COLORADO SUPREME COURT ORDERS CHILDREN’S HOSPITAL TO RESUME GENDER TRANSITION TREATMENTS FOR MINORS

“Today, we are ending federal taxpayer funding for sex-rejecting procedures on children,” Secretary Kennedy said in a statement to Fox News Digital. “These interventions carry serious risks and can cause irreversible harm. The federal government will no longer use Medicaid and CHIP dollars to fund procedures that fail to meet the evidentiary standard our children deserve.”

That research “identified significant evidence gaps” and “documented serious safety concerns,” eventually leading to the conclusion that taxpayer funding for such procedures could not be justified comparative to the risks.

Specifically, CMS pointed to the United Kingdom’s Cass Review as one of the cornerstone pieces of research informing the decision.

That review, conducted by Dr. Hilary Cass, concluded in 2024 that research on medical interventions like cross-sex hormones and puberty blockers was limited and not definitive. The report also said that medical interventions had developed significantly faster than evidence proving those interventions were safe.

LARGEST CHILDREN’S HOSPITAL IN US TO OPEN ‘DETRANSITION CLINIC’ AFTER $10M SETTLEMENT WITH TRUMP DOJ, STATE

“The Trump Administration is drawing a clear line: America’s children will not be subjected to life-altering interventions on the taxpayer’s dime without reliable evidence of safety and clinical benefit,” HHS Press Secretary Emily Hilliard told Fox News Digital.

“Under the leadership of Secretary Kennedy, federal health care dollars will support evidence-based care that protects children and puts their long-term health first,” she added. “American taxpayers should never be forced to finance interventions when the evidence of benefit is insufficient and the potential consequences for children can be serious and irreversible.”

What follows is a tapering-off period where the Medicaid and CHIP funding will slowly phase out and allow children who are currently getting hormone treatments to receive funding for six months from the date the new rule takes effect.

This post appeared first on https://www.foxnews.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
Joe Biden’s cancer has spread further, leaving him in ‘very painful’ condition, Hunter reveals
next post
Socialist winning streak puts prized Democratic battleground at risk as radical leftists advance

related articles

Springsteen, other stars share stage with hardcore leftist...

October 5, 2026

Trump drops Republican Senator’s phone number in social...

October 5, 2026

Firebrand GOP rep: Democrats side with Iran ‘simply...

October 5, 2026

Tennessee prison chief resigns after failed execution as...

October 5, 2026

10 Democrat-held House seats Republicans could flip to...

October 1, 2026

State’s largest mosque leader’s deportation fight takes dramatic...

October 1, 2026

Trump handing 1 million Americans Obamacare refund checks...

October 1, 2026

Iranian negotiators kicked out of US as talks...

October 1, 2026

Trump’s new high-tech government hub holds some bizarre...

October 1, 2026

FAA breaks controller hiring record after chief warned...

October 1, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Nikkei 225 Index outlook: Top catalysts for Japan stocks this week

    September 14, 2026
  • Emergency action seeks to prevent erasure of ‘mother’ and ‘father’ in code of largest US town

    June 10, 2026
  • Oracle shares rebound 6% after earnings selloff: what’s behind the move?

    June 15, 2026
  • Why is SanDisk stock rising today?

    June 10, 2026
  • Nike stock is near a 12-year low: here’s why earnings could change the story

    September 28, 2026

Popular Posts

  • 1

    Why SpaceX stock is down around 3% on Tuesday

    September 15, 2026
  • 2

    Micron stock falls 4%, why this analyst sees 40% upside for the stock?

    September 28, 2026
  • 3

    Evening digest: US jobs cool, gold falls as Treasury yields rise

    October 2, 2026
  • 4

    Nike stock sinks after earnings as its comeback plan turns into more layoffs

    October 2, 2026
  • 5

    Dow rises 260 points as weak jobs data lifts US stocks

    October 2, 2026

Categories

  • Editor's Pick (711)
  • Investing (2,690)
  • Stock (90)

Latest Posts

  • Why SpaceX stock is down around 1.5% today?

    October 7, 2026
  • Chicago’s deadly Juneteenth weekend leaves 7 dead as Trump shames Dem gov for inaction

    June 22, 2026
  • Nebius stock continues to fall as analysts cut target price

    November 16, 2026

Recent Posts

  • Why is Modine stock skyrocketing 29% after Samsung’s surprise takeover interest?

    November 13, 2026
  • Samsung, SK Hynix power Asia rebound while oil shock rattles bonds

    July 9, 2026
  • Corning stock falls: why are analysts backing the stock?

    July 7, 2026

Editor’s Pick

  • Amazon stock is struggling: will upcoming earnings ignite a comeback?

    July 17, 2026
  • Nvidia, AMD, Intel stocks fall despite record AI demand: has the easy money gone?

    October 8, 2026
  • SoftBank stock surges 13%: 4 reasons behind its unstoppable run

    June 15, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock